Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Collectively, these findings establish a mechanistic pathway whereby LEO restores dysregulated SCFA production in diabetic mice, highlighting dose-responsive butyrate accumulation as the dominant effector mediating enhanced GLP-1 secretion in functionally compromised enteroendocrine cells
Additional Potential Benefits Beyond sleep and stress, DSIP may provide other systemic advantages: Pain management: Preliminary studies suggest DSIP could influence pain pathways, potentially lowering pain perception
This seems likely to be mediated by inhibition of intestinal absorption via OATP1A2
DiMarchi happened to be interested in making a better version of synthetic glucagon that could be more easily administered
